跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 104,178 条关于
“Platinum-resistant ovarian cancer”
全部
104,178
临床试验
84,684
药物
2,407
机构
1,116
资讯
15,971
去年
Afuresertib Plus Paclitaxel Fails to Improve Survival in Platinum-Resistant Ovarian Cancer Trial
去年
Relacorilant Plus Nab-Paclitaxel Shows Promise in Platinum-Resistant Ovarian Cancer
2年前
Merck's KEYTRUDA Shows Promise in Platinum-Resistant Ovarian Cancer Trial
去年
Bio-Thera Solutions Initiates Phase 3 Trial for BAT8006 ADC in Platinum-Resistant Ovarian Cancer
10个月前
Dialectic Therapeutics Initiates Phase 1b/2 Trial of DT2216 in Platinum-Resistant Ovarian Cancer
11个月前
Light Chain Bioscience Reports Promising Survival Data for NI-1801 Bispecific Antibody in Platinum-Resistant Ovarian Cancer
去年
Luveltamab Tazevibulin Shows Promising Results in Platinum-Resistant Ovarian Cancer with Low to High FRα Expression
11个月前
Merck and Daiichi's Raludotatug Deruxtecan Shows 51% Response Rate in Platinum-Resistant Ovarian Cancer
去年
Sutro Biopharma Reports Promising Results for Luvelta in Platinum-Resistant Ovarian Cancer Trial
2个月前
Glenmark Advances Phase 3 Trial of Trastuzumab Rezetecan in Platinum-Resistant Ovarian Cancer Following DCGI Approval
第 1 页，共 1598 页
上一页
下一页
